Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsDoesn't the rule prohibiting Soc Sec from negotiating for lower drug prices date back to GWB?
I havent heard any journalist mention the fact that it was during the administration of GWB that this rule was imposed. When AARP supported the rule I quit that organization.
3 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
Doesn't the rule prohibiting Soc Sec from negotiating for lower drug prices date back to GWB? (Original Post)
Kyblue1
Aug 2022
OP
dflprincess
(29,135 posts)1. It does.
It happened when the Part D coverage was being negotiated.
Wounded Bear
(63,751 posts)2. Yes. It was baked into the Medicare Part D legislation...
by repubs, of course. Everybody else negotiates, that law explicitly forbids Medicare from doing it.
genxlib
(6,077 posts)3. It was worse than that
The Republican that was instrumental in putting the rule in went straight to work for the Pharma industry. It is one of the ugliest cases of payoff in recent history.
https://thehill.com/opinion/healthcare/374035-ex-congressman-still-costing-taxpayers-billions-in-prescription-fees/
Former Rep. Billy Tauzin (R,D-La.) and the Pharmaceutical Research and Manufacturers of America championed the non-interference clause being added to the Social Security law. According to 60 Minutes, Tauzin was responsible for successfully shepherding through Congress the bill limiting the governments ability to bargain for better drug prices.
This was quite a win for the pharmaceutical industry and a loss for the American taxpayer. What happened to Tauzin? Surprise, surprise, he retired from Congress sometime after securing the favorable restriction and accepted a position as president of a trade association where he received $2 million a year.
Which trade association is paying him $2 million a year? I know you will find this shocking: the Pharmaceutical Research and Manufacturers of America.